Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Biomarkers of Hemolysis, Hemostasis, and Endothelial Activation Are Associated with Clinical Outcomes in Children with Sickle Cell Disease: An 8-Year Prospective Study

Bushra Zucca, Alina Ferster, Laurence Rozen, Anne Demulder, Laurence Dedeken, Anna Vanderfaeillie, Phu-Quoc Le, Denis Noubouossie, Nicolas Lefèvre

Blood (2024) 144 (Supplement 1): 293.

https://doi.org/10.1182/blood-2024-209943

Published: 2024

Journal Articles

Factors Influencing Change in MCV and Age at Transplantation in the Belgian Sickle Cell Disease Registry

Sarah Wambacq, Beatrice Gulbis, Fleur Samantha Benghiat, Bénédicte Brichard, Bruwier Annelyse, Laurence Dedeken, Bram De Wilde, Marie-Françoise Dresse, Andre Efira, Catherine Heijmans, Veerle Labarque, Phu-Quoc Le, Philip Maes, Pierre Philippet, An Van Damme, Anna Vanderfaeillie, Alina Ferster

Blood (2021) 138 (Supplement 1): 4171.

https://doi.org/10.1182/blood-2021-145403

Published: 2021

Journal Articles

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Phu-Quoc Le, MD PhD, Beatrice Gulbis, MD PhD, Laurence Dedeken, MD, Laurence Rozen, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Fleur Samantha Benghiat, Andre Efira, MD, Marie-Françoise Dresse, MD PhD, Alina Ferster, MD

Blood (2018) 132 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2018-99-119319

Published: 2018

Journal Articles

Effects of Oral N -Acetylcysteine on Oxidative Stress in Patients with Sickle Cell Disease

Blood (2017) 130 (Supplement 1): 2244.

https://doi.org/10.1182/blood.V130.Suppl_1.2244.2244

Published: 2017

Journal Articles

N-Acetylcysteine in Patients with Sickle Cell Disease: A Randomized Controlled Trial

Blood (2016) 128 (22): 123.

https://doi.org/10.1182/blood.V128.22.123.123

Published: 2016

Journal Articles

Genetic Counseling in Hemoglobin SC Disease: Data from the Belgian Registry

Phu-Quoc Lê, MD, Alina Ferster, MD, Laurence Dedeken, MD, Laurence Rozen, PharmD, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Sophie Huybrechts, MD, Christine Devalck, MD, Catherine Heijmans, MD, Marie-Françoise Dresse, MD PhD, André Efira, MD, Samantha Benghiat, MD PhD, Sophie Dupont, MD, Beatrice Gulbis, MD PhD

Blood (2014) 124 (21): 4935.

https://doi.org/10.1182/blood.V124.21.4935.4935

Published: 2014

Journal Articles

Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

Phu-Quoc Lê, MD, Laurence Dedeken, MD, Beatrice Gulbis, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Sophie Huybrechts, MD, Samantha Benghiat, MD, André Efira, MD, Marie-Francoise Dresse, MD, Sophie Dupont, MD, Alina Ferster, MD

Blood (2013) 122 (21): 2231.

https://doi.org/10.1182/blood.V122.21.2231.2231

Published: 2013

Journal Articles

Newborn Screening for Sickle Cell Disease in Brussels, a Program with an Ongoing Clinical Outcome Improvement

Phu-Quoc Le, MD, Beatrice Gulbis, MD, PhD, Laurence Dedeken, MD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christiane Vermylen, MD, PhD, Sophie Huybrechts, MD, Christine Devalck, MD, Frederic Cotton, PhD, Ba Cuong Nguyen, Françoise Vertongen, MD, PhD, Malou Ngalula, Alina Ferster, MD

Blood (2012) 120 (21): 4757.

https://doi.org/10.1182/blood.V120.21.4757.4757

Published: 2012

Journal Articles

National Clinical Data Base for Sickle Cell Disease In Belgium

Phu-Quoc Lê, MD, Alina Ferster, MD, Françoise Vertongen, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, André Efira, MD, Ba-Cuong Nguyen, Malou Ngalula Mujinga, nurse, Beatrice Gulbis, MD, PhD

Blood (2010) 116 (21): 2659.

https://doi.org/10.1182/blood.V116.21.2659.2659

Published: 2010

Journal Articles

Possible Dose Adjustment of Hydroxyurea In Young Patients with Sickle Cell Disease and Followed In the Belgian Registry

Phu-Quoc Le, MD, Beatrice Gulbis, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Françoise Vertongen, MD, PhD, Alina Ferster, MD

Blood (2010) 116 (21): 4823.

https://doi.org/10.1182/blood.V116.21.4823.4823

Published: 2010

Journal Articles

Efficiency of the Neonatal Screening Program for Sickle Cell Disease. the Belgian Experience

Phu-Quoc Le, MD, Alina Ferster, MD, Françoise Vertongen, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Ba-Cuong Nguyen, Malou Ngalula Mijinga, nurse, Beatrice Gulbis, MD, PhD

Blood (2010) 116 (21): 4816.

https://doi.org/10.1182/blood.V116.21.4816.4816

Published: 2010

NARROW

Biomarkers of Hemolysis, Hemostasis, and Endothelial Activation Are Associated with Clinical Outcomes in Children with Sickle Cell Disease: An 8-Year Prospective Study

Factors Influencing Change in MCV and Age at Transplantation in the Belgian Sickle Cell Disease Registry

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Effects of Oral N -Acetylcysteine on Oxidative Stress in Patients with Sickle Cell Disease

N-Acetylcysteine in Patients with Sickle Cell Disease: A Randomized Controlled Trial

Genetic Counseling in Hemoglobin SC Disease: Data from the Belgian Registry

Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

Newborn Screening for Sickle Cell Disease in Brussels, a Program with an Ongoing Clinical Outcome Improvement

National Clinical Data Base for Sickle Cell Disease In Belgium

Possible Dose Adjustment of Hydroxyurea In Young Patients with Sickle Cell Disease and Followed In the Belgian Registry

Efficiency of the Neonatal Screening Program for Sickle Cell Disease. the Belgian Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only